NeoPharm CO. LTD (092730.KQ) stock: key figures, P/E, revenue and dividend
Consumer Staples · Personal Care Products · South Korea · ISIN KR7092730001
NeoPharm CO. LTD financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 119.01 bn KRW | 132.18 bn KRW |
| Gross profit | 74.03 bn KRW | 86.40 bn KRW |
| Operating income | 24.65 bn KRW | 28.77 bn KRW |
| EBIT | 30.25 bn KRW | 32.30 bn KRW |
| Net income | 23.06 bn KRW | 27.82 bn KRW |
| Diluted EPS – continuing operations | 1,474.61 KRW | 1,778.81 KRW |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About NeoPharm CO. LTD
NeoPharm CO., LTD. manufactures and sells skin care products in South Korea. The company offers Atopalm, a non-steroid product for sensitive and dry skin; skin dermo-cosmetic products under the Real Barrier brand; products for sensitive, dry, oily, or trouble-prone skin under the ZEROID brand; body moisturizers under the Derma-B brand; and sport care products for athletes under the MISSION ATHELETCARE brand. NeoPharm CO., LTD. was founded in 2000 and is headquartered in Daejeon, South Korea.
More stocks
- Polight ASA (PLT.OL)
- Cosmo Chem (005420.KS)
- Profit Cultural & Creative Group Co Ltd (300640.SZ)
- Nice Information & Telecommunication Inc (036800.KQ)
- Bookook Sec (001270.KS)
- ARBOR REALTY TRUST INC (ABR)
- MC Group Public Company Limited (MC.BK)
- Addcn Technology Co Ltd (5287.TWO)
- Holidaycheck Group (HOC.HM)
- Chongqing Wanli New Energy Co Ltd (600847.SS)
- Cruzeiro do Sul Educacional S.A (CSED3.SA)
- BICYCLE THERAPEUTICS PLC (BCYC)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.